Skip to content

Clinical trials

Phase 1/2 Frailty trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Frailty Phase: Phase 1/2 Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20141
20181
20201
20211
20221
20232
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Unknown status2
Active, not recruiting2
Withdrawn1
Not yet recruiting1
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bijan Najafi, PhD1
Cellcolabs Clinical LTD.1
Dipnarine Maharaj1
Iowa State University1
Longeveron Inc.1
Meribank Biotech Co., Ltd.1
University of Genova1
University of Maryland, Baltimore1
University of Pennsylvania1
Unlimited Biotechnology LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Frailty12
Sarcopenia2
Arthritis1
Breast Neoplasms1
Immune System Diseases1
Inflammation1
Muscle Weakness1
Muscular Atrophy1
Osteoporosis1
Pathologic Processes1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.